All Insights
Showing 1 - 12 of 383
Life Sciences and Healthcare
Supplements from lab to label: the compliance checklist
From concept and formulation through ingredient due diligence and safety, novel food assessments, claims and advertising, labelling and post‑market surveillance
Life Sciences and Healthcare
EU overhauls pharmaceutical law with sweeping 2026 reform package
Landmark reform overhauls incentives, supply obligations and regulatory pathways for pharmaceuticals operating in Europe
Life Sciences and Healthcare
Nagoya Protocol compliance shapes EU sourcing of genetic resources for R&D
Life sciences, food and cosmetics businesses using biological materials should assess their exposure to ABS obligations
Regulatory Outlook
Products | UK Regulatory Outlook March 2026
General/digital products: Consultation on unregulated construction products | Commission consults on draft guidance for the EU Cyber Resilience Act |
Corporate
How American capital pursuing Belgian investment or acquisition targets can mitigate deal‑breaker risks
US funds willing to invest in or acquire Belgian companies face pitfalls – good planning and advisers can drive success
Regulatory and compliance
Weighty matters: GLP-1s and the UK regulatory diet they cannot escape
As weight-loss medicines drive rapid shifts in consumer behaviour, food, retail and digital health businesses are racing to respond, with
Life Sciences and Healthcare
EU drug agency proposes permanent clinical trial flexibility framework for crisis times
Expedited approvals, remote monitoring and decentralised elements anchor proposed EU trial rules for emergencies
Competition, antitrust and trade
CMA sets out new guidance on collaborations between UK universities and research institutions
The guidance identifies what higher education providers can and cannot do as they look to work more closely together
Life Sciences and Healthcare
Italy's Sunshine Act: a system ready but still not operational
Although reporting obligations are not yet in force, operators should prepare for the necessary internal adjustments
Regulatory Outlook
Products | UK Regulatory Outlook February 2026
General/digital products: EU product compliance: digitalisation and common specifications proposals | Proposal to amend EU regulations on AI rules Life
Life Sciences and Healthcare
Enactment of BBNJ Act brings UK closer to ratifying High Seas Treaty
Secondary legislation still required to meet treaty obligations before ratification
